Pfizer (US:PFE) — Company Overview, News & Financial Data
Pfizer is a global biopharmaceutical company focused on developing medicines and vaccines for various diseases, enhancing global health.
PFEPfizer
Company profile
About Pfizer
Pfizer (NYSE:PFE) is a global biopharmaceutical company with a diverse range of products and services aimed at improving health and well-being. It focuses on developing, manufacturing, and distributing medicines and vaccines for a wide spectrum of diseases, including immunology, oncology, cardiology, and neurology. Among its numerous projects, Pfizer is renowned for its rapid development of a COVID-19 vaccine, showcasing its commitment to addressing global health emergencies. Furthermore, the company's objectives revolve around innovation in medicine, striving to provide access to safe and effective healthcare solutions across the globe. Pfizer emphasizes sustainability in its operations, aiming to reduce its environmental impact while improving the quality of life for patients worldwide.
Snapshot
Public USOwnership
1849Year founded
102047Employees
New York, United StatesHead office
Loading Map...
Global footprint
Operations
All Locations
New York City, US
Products and/or services of Pfizer
- Novel medicines targeting a variety of conditions are a primary focus, with an extensive portfolio covering vaccines, oncology, and rare diseases.
- Advancements in gene therapy offer revolutionary treatments for genetic and acquired diseases through the customization of patients' own cells.
- The globally recognized blue pill, Viagra, remains a leading treatment for erectile dysfunction, enhancing male sexual function.
- Consumer-oriented products such as Advil and Centrum provide everyday health benefits in a trusted, over-the-counter format.
- The Prevnar 13 vaccine safeguards against pneumococcal disease in both pediatric and adult populations.
- Chantix, a proven smoking cessation therapy, assists individuals aiming to quit by reducing the pleasurable effects of nicotine.
Pfizer executive team
- Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & CEO
- Mr. David M. DentonExecutive VP & CFO
- Dr. Chris Boshoff FMedSci, M.D., Ph.D.Chief Scientific Officer and President of Research & Development
- Mr. Aamir MalikExecutive VP & Chief U.S. Commercial Officer
- Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting Officer
- Ms. Lidia L. FonsecaExecutive VP and Chief Digital & Technology Officer
- Ms. Francesca M. DeMartinoChief Investor Relations Officer
- Mr. Douglas M. LanklerExecutive VP & Chief Legal Officer
- Ms. Payal Sahni BecherChief People Experience Officer & Executive VP
- Ms. Sally M. SusmanExecutive VP & Chief Corporate Affairs Officer